Recognizing the critical importance of public health, Bepharco Pharmaceutical Joint Stock Company has committed to partnering with Gedeon Richter in the specialized seminar "Heart Failure - Resistant Hypertension.

Overview of the Specialized Seminar on "Heart Failure - Resistant Hypertension"

According to the Asia Pacific Society of Cardiology (APSC) Conference 2023, 58% of global cardiovascular-related deaths occur in the Asia-Pacific region. This figure reflects an alarming reality, posing a significant challenge not only for the local populations but also for the healthcare sectors of the countries in this region.

Recognizing the critical importance of public health, Bepharco Pharmaceutical Joint Stock Company has committed to partnering with Gedeon Richter—one of the leading and most reputable pharmaceutical companies with over 120 years of history—in a joint effort to contribute to the journey of improving public health

Guest Speakers' Insights
Recently, on May 9, 2024, the specialized seminar "Heart Failure - Resistant Hypertension" was successfully held under the chairmanship of Specialist Doctor II Le Ha Minh Giang, Head of the Geriatrics Department at Binh Duong General Hospital, and Pharmacist Tran Quang Huy. At the event, over 100 guests, including pharmacists, clinic doctors, and other healthcare professionals, took the time to attend, listen, and exchange valuable information and knowledge. This not only contributed to the overall development of the field but also provided practical value to the community.

Bepharco and Gedeon Richter extend our heartfelt thanks to you. We appreciate everyone's ongoing support and companionship as we strive for a healthier community.